Markets By TradingView
7268
0

11.05.2020 GILD Daily Analysis

Gilead Sciences (NASDAQ:GILD) is the most pharmaceutical company spoken about these days, with its antiviral remdesivir drug being the hottest drug

Yazar: editor_1

Yayınlanma: 12 Mayıs 2020 00:30

Güncellenme: 14 Kasım 2024 23:32

11.05.2020 GILD Daily Analysis

Gilead Sciences (NASDAQ:GILD) is the most pharmaceutical company spoken about these days, with its antiviral remdesivir drug being the hottest drug at the moment according to its apparent success in clinical trials with patients who have COVID-19. On Saturday, The U.S. Department of Health and Human Services (HHS) said it'll allow the state health departments to distribute Gilead Sciences Inc (NASDAQ:GILD)'s remdesivir drug to help fight the COVID-19, and that the U.S. is said to receive 40% of the global donations made by the drugmaker. Gilead Sciences Inc (GILD) is down by $0.12, or by -0.15%, at $77.49.
En Popüler Haberler

Yorum Yap

Yazılan yorumlar hiçbir şekilde Son Ekonomi Haberleri - Türkiye Dünya - ieconomy.io görüş ve düşüncelerini yansıtmamaktadır. Yorumlar, yazan kişiyi bağlayıcı niteliktedir.

Yorumlar

Henüz yorum yapan yok! İlk yorumu siz yapın...

Borsa, Kripto, Hisse, Emtia ve Döviz Haberleri

ieconomy: Türkiye'nin en kapsamlı ekonomi haber sitesi. Son dakika haberleri ve en güncel haberler ieconomy'da.